Emrise Company Profile (OTCMKTS:EMRI)

About Emrise (OTCMKTS:EMRI)

Emrise logoEMRISE Corporation (EMRISE) designs, manufactures and markets electronic devices, sub-systems and equipment for aerospace, defense, industrial and communications markets. The Company's products perform key functions such as power supply and power conversion; radio frequency (RF) and microwave signal conditioning; and network access and timing and synchronization of communications networks. It conducts its business through two operating segments: electronic devices and communications equipment. The Company's two electronic devices segment business units, XCEL Power Systems Ltd. (XPS) and Pascall Electronics Limited (PEL), are located in the United Kingdom. The Company's two communications equipment business units, CXR Larus Corporation (CXR Larus) and CXR Anderson-Jacobson (CXR AJ), are located in the United States and France, respectively.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:EMRI
  • CUSIP: N/A
  • Web: www.emrise.com
Average Prices:
    P/E:
    • Trailing P/E Ratio:
    • P/E Growth:
    Profitability:
    • Return on Equity: -26.51%
    • Return on Assets: -11.60%
     
    Frequently Asked Questions for Emrise (OTCMKTS:EMRI)

    What is Emrise's stock symbol?

    Emrise trades on the OTCMKTS under the ticker symbol "EMRI."

    Who are some of Emrise's key competitors?

    How do I buy Emrise stock?

    Shares of Emrise can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

    What is Emrise's stock price today?

    One share of Emrise stock can currently be purchased for approximately $1.11.


    MarketBeat Community Rating for Emrise (OTCMKTS EMRI)
    Community Ranking:  2.2 out of 5 ( )
    Outperform Votes:  4 (Vote Outperform)
    Underperform Votes:  5 (Vote Underperform)
    Total Votes:  9
    MarketBeat's community ratings are surveys of what our community members think about Emrise and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

    Analyst Ratings

    Consensus Ratings for Emrise (OTCMKTS:EMRI) (How are Consensus Ratings Calculated?)
    Ratings Breakdown: No ratings tracked in the last 12 months.
    Consensus Rating:N/A (Score: NaN)
    Consensus Price Target: N/A

    Analysts' Ratings History for Emrise (OTCMKTS:EMRI)
    Show:
    No equities research coverage for this company has been tracked by MarketBeat.com

    Earnings

    Earnings History for Emrise (OTCMKTS:EMRI)
    Earnings by Quarter for Emrise (OTCMKTS:EMRI)
    Earnings History by Quarter for Emrise (OTCMKTS EMRI)
    DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
    8/14/2013Q2 2013($0.01)ViewN/AView Earnings Details
    5/13/2013($0.05)ViewN/AView Earnings Details
    3/28/2013Q4 12$0.04ViewN/AView Earnings Details
    (Data available from 1/1/2011 forward)

    Estimates

    Earnings Estimates for Emrise (OTCMKTS:EMRI)

    No earnings estimates for this company have been tracked by MarketBeat.com

    Dividends

    Dividend History for Emrise (OTCMKTS:EMRI)
    No dividend announcements for this company have been tracked by MarketBeat.com

    Insider Trades

    Insider Trading and Institutional Ownership History for Emrise (OTCMKTS:EMRI)
    Insider Trades by Quarter for Emrise (OTCMKTS:EMRI)
    Insider Trades by Quarter for Emrise (OTCMKTS:EMRI)
    Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
    7/1/2015Poplar Point Capital PartnersMajor ShareholderBuy163,351$1.12$182,953.12View SEC Filing  
    6/7/2013Carmine T OlivaCEOBuy5,000$0.54$2,700.00View SEC Filing  
    5/30/2013Frank P RussomannoDirectorBuy4,987$0.53$2,643.11View SEC Filing  
    5/23/2013Julie AbrahamDirectorBuy5,000$0.54$2,700.00View SEC Filing  
    12/11/2012Carmine T OlivaCEOBuy10,000$0.46$4,600.00View SEC Filing  
    11/29/2012Frank P RussomannoDirectorBuy5,000$0.45$2,250.00View SEC Filing  
    9/7/2012Graham JefferiesCOOBuy2,000$0.69$1,380.00View SEC Filing  
    8/30/2012Julie AbrahamDirectorBuy5,000$0.70$3,500.00View SEC Filing  
    (Data available from 1/1/2013 forward)

    Headlines

    Headline Trends for Emrise (OTCMKTS:EMRI)
    Latest Headlines for Emrise (OTCMKTS:EMRI)
    Source:
    No headlines for this company have been tracked by MarketBeat.com

    Social

    Chart

    Emrise (EMRI) Chart for Monday, July, 24, 2017

    This page was last updated on 7/24/2017 by MarketBeat.com Staff